APO Research
Talk to an analyst

APO RESEARCH · REPORT

Octreotide

Octreotide is an octapeptide that mimics natural somatostatin pharmacologically，it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. Usually in the form of a salt of acetic acid.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Octreotide is an octapeptide that mimics natural somatostatin pharmacologically，it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. Usually in the form of a salt of acetic acid.

Selected research

Market Analysis & Forecast

Global Octreotide Market Analysis and Forecast 2026-2032

22 December 2025199 pages

Choose your research edition.

Industry ResearchOctreotide Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Octreotide Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Octreotide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Octreotide Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Octreotide Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

Octreotide is an octapeptide that mimics natural somatostatin pharmacologically，it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. Usually in the form of a salt of acetic acid.

Global Octreotide key players include Novartis, SUN, Tiantaishan pharmaceutical, Sinopharm A-Think, Sihuan Pharmaceutical, etc. Global top five manufacturers hold a share over 90%.

Europe is the largest market, with a share over 65%, followed by India and China, both have a share over 30%.

Read the full market overview

This report presents an overview of global market for Octreotide, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Octreotide, also provides the sales of main regions and countries. Of the upcoming market potential for Octreotide, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Octreotide sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Octreotide market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Octreotide sales, projected growth trends, production technology, application and end-user industry.

Octreotide Segment by Company

Novartis

Sun Pharmaceutical

Chengdu Tiantaishan pharmaceutical

Sinopharm A-Think Pharmaceuticals

Sihuan Pharmaceutical Holdings Group

Shanghai Soho-Yiming Pharmaceuticals

Yibin Pharmaceutical

Octreotide Segment by Type

Octreotide Injection

Octreotide Powder

Octreotide Microspheres

Octreotide Segment by Application

Treating Severe Diarrhea

Treating Acromegaly

Others

Octreotide Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Octreotide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Octreotide and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Octreotide.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Octreotide in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Octreotide manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Octreotide sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Octreotide Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Octreotide Injection Major Manufacturers Table 3. Octreotide Powder Major Manufacturers Table 4. Octreotide Microspheres Major Manufacturers Table 5. Global Octreotide Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Treating Severe Diarrhea Major Manufacturers Table 7. Treating Acromegaly Major Manufacturers Table 8. Others Major Manufacturers Table 9. Octreotide Industry Trends Table 10. Octreotide Industry Drivers Table 11. Octreotide Industry Opportunities and Challenges Table 12. Octreotide Industry Restraints Table 13. Global Octreotide Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Octreotide Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Octreotide Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Octreotide Revenue Market Share by Region (2021-2026) Table 17. Global Octreotide Revenue Market Share by Region (2027-2032) Table 18. Global Octreotide Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (Gram) Table 19. Global Octreotide Sales by Region (2021-2026) & (Gram) Table 20. Global Octreotide Sales by Region (2027-2032) & (Gram) Table 21. Global Octreotide Sales Market Share by Region (2021-2026) Table 22. Global Octreotide Sales Market Share by Region (2027-2032) Table 23. Global Octreotide Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Octreotide Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Octreotide Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Octreotide Sales Market Share by Manufacturers (2021-2026) Table 27. Global Octreotide Sales Price (USD/Gram) of Manufacturers (2021-2026) Table 28. Global Octreotide Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Octreotide Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Octreotide Manufacturers, Product Type & Application Table 31. Global Octreotide Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Octreotide by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Octreotide Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Octreotide Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Octreotide Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Octreotide Revenue Market Share by Type (2021-2026) Table 38. Global Octreotide Revenue Market Share by Type (2027-2032) Table 39. Global Octreotide Sales by Type 2021 VS 2025 VS 2032 (Gram) Table 40. Global Octreotide Sales by Type (2021-2026) & (Gram) Table 41. Global Octreotide Sales by Type (2027-2032) & (Gram) Table 42. Global Octreotide Sales Market Share by Type (2021-2026) Table 43. Global Octreotide Sales Market Share by Type (2027-2032) Table 44. Global Octreotide Price by Type (2021-2026) & (USD/Gram) Table 45. Global Octreotide Price by Type (2027-2032) & (USD/Gram) Table 46. Global Octreotide Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Octreotide Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Octreotide Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Octreotide Revenue Market Share by Application (2021-2026) Table 50. Global Octreotide Revenue Market Share by Application (2027-2032) Table 51. Global Octreotide Sales by Application 2021 VS 2025 VS 2032 (Gram) Table 52. Global Octreotide Sales by Application (2021-2026) & (Gram) Table 53. Global Octreotide Sales by Application (2027-2032) & (Gram) Table 54. Global Octreotide Sales Market Share by Application (2021-2026) Table 55. Global Octreotide Sales Market Share by Application (2027-2032) Table 56. Global Octreotide Price by Application (2021-2026) & (USD/Gram) Table 57. Global Octreotide Price by Application (2027-2032) & (USD/Gram) Table 58. Novartis Company Information Table 59. Novartis Business Overview Table 60. Novartis Octreotide Sales (Gram), Revenue (US$ Million), Price (USD/Gram) and Gross Margin (2021-2026) Table 61. Novartis Octreotide Product Portfolio Table 62. Novartis Recent Development Table 63. Sun Pharmaceutical Company Information Table 64. Sun Pharmaceutical Business Overview Table 65. Sun Pharmaceutical Octreotide Sales (Gram), Revenue (US$ Million), Price (USD/Gram) and Gross Margin (2021-2026) Table 66. Sun Pharmaceutical Octreotide Product Portfolio Table 67. Sun Pharmaceutical Recent Development Table 68. Chengdu Tiantaishan pharmaceutical Company Information Table 69. Chengdu Tiantaishan pharmaceutical Business Overview Table 70. Chengdu Tiantaishan pharmaceutical Octreotide Sales (Gram), Revenue (US$ Million), Price (USD/Gram) and Gross Margin (2021-2026) Table 71. Chengdu Tiantaishan pharmaceutical Octreotide Product Portfolio Table 72. Chengdu Tiantaishan pharmaceutical Recent Development Table 73. Sinopharm A-Think Pharmaceuticals Company Information Table 74. Sinopharm A-Think Pharmaceuticals Business Overview Table 75. Sinopharm A-Think Pharmaceuticals Octreotide Sales (Gram), Revenue (US$ Million), Price (USD/Gram) and Gross Margin (2021-2026) Table 76. Sinopharm A-Think Pharmaceuticals Octreotide Product Portfolio Table 77. Sinopharm A-Think Pharmaceuticals Recent Development Table 78. Sihuan Pharmaceutical Holdings Group Company Information Table 79. Sihuan Pharmaceutical Holdings Group Business Overview Table 80. Sihuan Pharmaceutical Holdings Group Octreotide Sales (Gram), Revenue (US$ Million), Price (USD/Gram) and Gross Margin (2021-2026) Table 81. Sihuan Pharmaceutical Holdings Group Octreotide Product Portfolio Table 82. Sihuan Pharmaceutical Holdings Group Recent Development Table 83. Shanghai Soho-Yiming Pharmaceuticals Company Information Table 84. Shanghai Soho-Yiming Pharmaceuticals Business Overview Table 85. Shanghai Soho-Yiming Pharmaceuticals Octreotide Sales (Gram), Revenue (US$ Million), Price (USD/Gram) and Gross Margin (2021-2026) Table 86. Shanghai Soho-Yiming Pharmaceuticals Octreotide Product Portfolio Table 87. Shanghai Soho-Yiming Pharmaceuticals Recent Development Table 88. Yibin Pharmaceutical Company Information Table 89. Yibin Pharmaceutical Business Overview Table 90. Yibin Pharmaceutical Octreotide Sales (Gram), Revenue (US$ Million), Price (USD/Gram) and Gross Margin (2021-2026) Table 91. Yibin Pharmaceutical Octreotide Product Portfolio Table 92. Yibin Pharmaceutical Recent Development Table 93. North America Octreotide Revenue by Type (2021-2026) & (US$ Million) Table 94. North America Octreotide Revenue by Type (2027-2032) & (US$ Million) Table 95. North America Octreotide Sales by Type (2021-2026) & (Gram) Table 96. North America Octreotide Sales by Type (2027-2032) & (Gram) Table 97. North America Octreotide Sales Price by Type (2021-2026) & (USD/Gram) Table 98. North America Octreotide Sales Price by Type (2027-2032) & (USD/Gram) Table 99. North America Octreotide Revenue by Application (2021-2026) & (US$ Million) Table 100. North America Octreotide Revenue by Application (2027-2032) & (US$ Million) Table 101. North America Octreotide Sales by Application (2021-2026) & (Gram) Table 102. North America Octreotide Sales by Application (2027-2032) & (Gram) Table 103. North America Octreotide Sales Price by Application (2021-2026) & (USD/Gram) Table 104. North America Octreotide Sales Price by Application (2027-2032) & (USD/Gram) Table 105. North America Octreotide Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 106. North America Octreotide Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 107. North America Octreotide Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 108. North America Octreotide Sales by Country (2021 VS 2025 VS 2032) & (Gram) Table 109. North America Octreotide Sales by Country (2021-2026) & (Gram) Table 110. North America Octreotide Sales by Country (2027-2032) & (Gram) Table 111. North America Octreotide Sales Price by Country (2021-2026) & (USD/Gram) Table 112. North America Octreotide Sales Price by Country (2027-2032) & (USD/Gram) Table 113. United States Octreotide Revenue (2021-2032) & (US$ Million) Table 114. Canada Octreotide Revenue (2021-2032) & (US$ Million) Table 115. Mexico Octreotide Revenue (2021-2032) & (US$ Million) Table 116. Europe Octreotide Revenue by Type (2021-2026) & (US$ Million) Table 117. Europe Octreotide Revenue by Type (2027-2032) & (US$ Million) Table 118. Europe Octreotide Sales by Type (2021-2026) & (Gram) Table 119. Europe Octreotide Sales by Type (2027-2032) & (Gram) Table 120. Europe Octreotide Sales Price by Type (2021-2026) & (USD/Gram) Table 121. Europe Octreotide Sales Price by Type (2027-2032) & (USD/Gram) Table 122. Europe Octreotide Revenue by Application (2021-2026) & (US$ Million) Table 123. Europe Octreotide Revenue by Application (2027-2032) & (US$ Million) Table 124. Europe Octreotide Sales by Application (2021-2026) & (Gram) Table 125. Europe Octreotide Sales by Application (2027-2032) & (Gram) Table 126. Europe Octreotide Sales Price by Application (2021-2026) & (USD/Gram) Table 127. Europe Octreotide Sales Price by Application (2027-2032) & (USD/Gram) Table 128. Europe Octreotide Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 129. Europe Octreotide Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 130. Europe Octreotide Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 131. Europe Octreotide Sales by Country (2021 VS 2025 VS 2032) & (Gram) Table 132. Europe Octreotide Sales by Country (2021-2026) & (Gram) Table 133. Europe Octreotide Sales by Country (2027-2032) & (Gram) Table 134. Europe Octreotide Sales Price by Country (2021-2026) & (USD/Gram) Table 135. Europe Octreotide Sales Price by Country (2027-2032) & (USD/Gram) Table 136. Germany Octreotide Revenue (2021-2032) & (US$ Million) Table 137. France Octreotide Revenue (2021-2032) & (US$ Million) Table 138. U.K. Octreotide Revenue (2021-2032) & (US$ Million) Table 139. Italy Octreotide Revenue (2021-2032) & (US$ Million) Table 140. Russia Octreotide Revenue (2021-2032) & (US$ Million) Table 141. Spain Octreotide Revenue (2021-2032) & (US$ Million) Table 142. Netherlands Octreotide Revenue (2021-2032) & (US$ Million) Table 143. Switzerland Octreotide Revenue (2021-2032) & (US$ Million) Table 144. Sweden Octreotide Revenue (2021-2032) & (US$ Million) Table 145. Poland Octreotide Revenue (2021-2032) & (US$ Million) Table 146. China Octreotide Revenue by Type (2021-2026) & (US$ Million) Table 147. China Octreotide Revenue by Type (2027-2032) & (US$ Million) Table 148. China Octreotide Sales by Type (2021-2026) & (Gram) Table 149. China Octreotide Sales by Type (2027-2032) & (Gram) Table 150. China Octreotide Sales Price by Type (2021-2026) & (USD/Gram) Table 151. China Octreotide Sales Price by Type (2027-2032) & (USD/Gram) Table 152. China Octreotide Revenue by Application (2021-2026) & (US$ Million) Table 153. China Octreotide Revenue by Application (2027-2032) & (US$ Million) Table 154. China Octreotide Sales by Application (2021-2026) & (Gram) Table 155. China Octreotide Sales by Application (2027-2032) & (Gram) Table 156. China Octreotide Sales Price by Application (2021-2026) & (USD/Gram) Table 157. China Octreotide Sales Price by Application (2027-2032) & (USD/Gram) Table 158. Asia Octreotide Revenue by Type (2021-2026) & (US$ Million) Table 159. Asia Octreotide Revenue by Type (2027-2032) & (US$ Million) Table 160. Asia Octreotide Sales by Type (2021-2026) & (Gram) Table 161. Asia Octreotide Sales by Type (2027-2032) & (Gram) Table 162. Asia Octreotide Sales Price by Type (2021-2026) & (USD/Gram) Table 163. Asia Octreotide Sales Price by Type (2027-2032) & (USD/Gram) Table 164. Asia Octreotide Revenue by Application (2021-2026) & (US$ Million) Table 165. Asia Octreotide Revenue by Application (2027-2032) & (US$ Million) Table 166. Asia Octreotide Sales by Application (2021-2026) & (Gram) Table 167. Asia Octreotide Sales by Application (2027-2032) & (Gram) Table 168. Asia Octreotide Sales Price by Application (2021-2026) & (USD/Gram) Table 169. Asia Octreotide Sales Price by Application (2027-2032) & (USD/Gram) Table 170. Asia Octreotide Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 171. Asia Octreotide Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 172. Asia Octreotide Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 173. Asia Octreotide Sales by Country (2021 VS 2025 VS 2032) & (Gram) Table 174. Asia Octreotide Sales by Country (2021-2026) & (Gram) Table 175. Asia Octreotide Sales by Country (2027-2032) & (Gram) Table 176. Asia Octreotide Sales Price by Country (2021-2026) & (USD/Gram) Table 177. Asia Octreotide Sales Price by Country (2027-2032) & (USD/Gram) Table 178. Japan Octreotide Revenue (2021-2032) & (US$ Million) Table 179. South Korea Octreotide Revenue (2021-2032) & (US$ Million) Table 180. India Octreotide Revenue (2021-2032) & (US$ Million) Table 181. Australia Octreotide Revenue (2021-2032) & (US$ Million) Table 182. Taiwan Octreotide Revenue (2021-2032) & (US$ Million) Table 183. Southeast Asia Octreotide Revenue (2021-2032) & (US$ Million) Table 184. SAMEA Octreotide Revenue by Type (2021-2026) & (US$ Million) Table 185. SAMEA Octreotide Revenue by Type (2027-2032) & (US$ Million) Table 186. SAMEA Octreotide Sales by Type (2021-2026) & (Gram) Table 187. SAMEA Octreotide Sales by Type (2027-2032) & (Gram) Table 188. SAMEA Octreotide Sales Price by Type (2021-2026) & (USD/Gram) Table 189. SAMEA Octreotide Sales Price by Type (2027-2032) & (USD/Gram) Table 190. SAMEA Octreotide Revenue by Application (2021-2026) & (US$ Million) Table 191. SAMEA Octreotide Revenue by Application (2027-2032) & (US$ Million) Table 192. SAMEA Octreotide Sales by Application (2021-2026) & (Gram) Table 193. SAMEA Octreotide Sales by Application (2027-2032) & (Gram) Table 194. SAMEA Octreotide Sales Price by Application (2021-2026) & (USD/Gram) Table 195. SAMEA Octreotide Sales Price by Application (2027-2032) & (USD/Gram) Table 196. SAMEA Octreotide Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 197. SAMEA Octreotide Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 198. SAMEA Octreotide Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 199. SAMEA Octreotide Sales by Country (2021 VS 2025 VS 2032) & (Gram) Table 200. SAMEA Octreotide Sales by Country (2021-2026) & (Gram) Table 201. SAMEA Octreotide Sales by Country (2027-2032) & (Gram) Table 202. SAMEA Octreotide Sales Price by Country (2021-2026) & (USD/Gram) Table 203. SAMEA Octreotide Sales Price by Country (2027-2032) & (USD/Gram) Table 204. Brazil Octreotide Revenue (2021-2032) & (US$ Million) Table 205. Argentina Octreotide Revenue (2021-2032) & (US$ Million) Table 206. Chile Octreotide Revenue (2021-2032) & (US$ Million) Table 207. Colombia Octreotide Revenue (2021-2032) & (US$ Million) Table 208. Peru Octreotide Revenue (2021-2032) & (US$ Million) Table 209. Saudi Arabia Octreotide Revenue (2021-2032) & (US$ Million) Table 210. Israel Octreotide Revenue (2021-2032) & (US$ Million) Table 211. UAE Octreotide Revenue (2021-2032) & (US$ Million) Table 212. Turkey Octreotide Revenue (2021-2032) & (US$ Million) Table 213. Iran Octreotide Revenue (2021-2032) & (US$ Million) Table 214. Egypt Octreotide Revenue (2021-2032) & (US$ Million) Table 215. Key Raw Materials Table 216. Raw Materials Key Suppliers Table 217. Octreotide Distributors List Table 218. Octreotide Customers List Table 219. Research Programs/Design for This Report Table 220. Authors List of This Report Table 221. Secondary Sources Table 222. Primary Sources List of Figures Figure 1. Octreotide Image Figure 2. Global Octreotide Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Octreotide Market Size Share 2021 VS 2025 VS 2032 Figure 4. Octreotide Injection Image Figure 5. Octreotide Powder Image Figure 6. Octreotide Microspheres Image Figure 7. Global Octreotide Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Octreotide Market Size Share 2021 VS 2025 VS 2032 Figure 9. Treating Severe Diarrhea Image Figure 10. Treating Acromegaly Image Figure 11. Others Image Figure 12. Global Octreotide Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Octreotide Revenue (2021-2032) & (US$ Million) Figure 14. Global Octreotide Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Octreotide Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Octreotide Revenue Market Share by Region (2021-2032) Figure 17. Global Octreotide Sales (2021-2032) & (Gram) Figure 18. Global Octreotide Sales by Region: 2021 VS 2025 VS 2032 (Gram) Figure 19. Global Octreotide Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Octreotide Sales YoY (2021-2032) & (Gram) Figure 21. Europe Octreotide Sales YoY (2021-2032) & (Gram) Figure 22. China Octreotide Sales YoY (2021-2032) & (Gram) Figure 23. Asia (Excluding China) Octreotide Sales YoY (2021-2032) & (Gram) Figure 24. South America, Middle East and Africa Octreotide Sales YoY (2021-2032) & (Gram) Figure 25. Global Octreotide Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Octreotide Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Octreotide Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Octreotide Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Octreotide Revenue Market Share by Type (2021-2032) Figure 31. Global Octreotide Sales by Type (2021 VS 2025 VS 2032) & (Gram) Figure 32. Global Octreotide Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Octreotide Sales Market Share by Type (2021-2032) Figure 34. Global Octreotide Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Octreotide Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Octreotide Revenue Market Share by Application (2021-2032) Figure 37. Global Octreotide Sales by Application (2021 VS 2025 VS 2032) & (Gram) Figure 38. Global Octreotide Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Octreotide Sales Market Share by Application (2021-2032) Figure 40. North America Octreotide Revenue Share by Type (2021-2032) Figure 41. North America Octreotide Sales Share by Type (2021-2032) Figure 42. North America Octreotide Revenue Share by Application (2021-2032) Figure 43. North America Octreotide Sales Share by Application (2021-2032) Figure 44. North America Octreotide Revenue Share by Country (2021-2032) Figure 45. North America Octreotide Sales Share by Country (2021-2032) Figure 46. Europe Octreotide Revenue Share by Type (2021-2032) Figure 47. Europe Octreotide Sales Share by Type (2021-2032) Figure 48. Europe Octreotide Revenue Share by Application (2021-2032) Figure 49. Europe Octreotide Sales Share by Application (2021-2032) Figure 50. Europe Octreotide Revenue Share by Country (2021-2032) Figure 51. Europe Octreotide Sales Share by Country (2021-2032) Figure 52. China Octreotide Revenue Share by Type (2021-2032) Figure 53. China Octreotide Sales Share by Type (2021-2032) Figure 54. China Octreotide Revenue Share by Application (2021-2032) Figure 55. China Octreotide Sales Share by Application (2021-2032) Figure 56. Asia Octreotide Revenue Share by Type (2021-2032) Figure 57. Asia Octreotide Sales Share by Type (2021-2032) Figure 58. Asia Octreotide Revenue Share by Application (2021-2032) Figure 59. Asia Octreotide Sales Share by Application (2021-2032) Figure 60. Asia Octreotide Revenue Share by Country (2021-2032) Figure 61. Asia Octreotide Sales Share by Country (2021-2032) Figure 62. SAMEA Octreotide Revenue Share by Type (2021-2032) Figure 63. SAMEA Octreotide Sales Share by Type (2021-2032) Figure 64. SAMEA Octreotide Revenue Share by Application (2021-2032) Figure 65. SAMEA Octreotide Sales Share by Application (2021-2032) Figure 66. SAMEA Octreotide Revenue Share by Country (2021-2032) Figure 67. SAMEA Octreotide Sales Share by Country (2021-2032) Figure 68. Octreotide Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Octreotide Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Octreotide Injection
  • Octreotide Powder
  • Octreotide Microspheres
Applications
  • Treating Severe Diarrhea
  • Treating Acromegaly
  • Others
Companies covered
  • Novartis
  • Sun Pharmaceutical
  • Chengdu Tiantaishan pharmaceutical
  • Sinopharm A-Think Pharmaceuticals
  • Sihuan Pharmaceutical Holdings Group
  • Shanghai Soho-Yiming Pharmaceuticals
  • Yibin Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Octreotide Market by Type
  3. 1.2.1 Global Octreotide Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Octreotide Injection
  5. 1.2.3 Octreotide Powder
  6. 1.2.4 Octreotide Microspheres
  7. 1.3 Octreotide Market by Application
  8. 1.3.1 Global Octreotide Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Treating Severe Diarrhea
  10. 1.3.3 Treating Acromegaly
  11. 1.3.4 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Octreotide Market Dynamics
  1. 2.1 Octreotide Industry Trends
  2. 2.2 Octreotide Industry Drivers
  3. 2.3 Octreotide Industry Opportunities and Challenges
  4. 2.4 Octreotide Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Octreotide Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Octreotide Revenue by Region
  3. 3.2.1 Global Octreotide Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Octreotide Revenue by Region (2021-2026)
  5. 3.2.3 Global Octreotide Revenue by Region (2027-2032)
  6. 3.2.4 Global Octreotide Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Octreotide Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Octreotide Sales by Region
  9. 3.4.1 Global Octreotide Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Octreotide Sales by Region (2021-2026)
  11. 3.4.3 Global Octreotide Sales by Region (2027-2032)
  12. 3.4.4 Global Octreotide Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Octreotide Revenue by Manufacturers
  2. 4.1.1 Global Octreotide Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Octreotide Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Octreotide Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Octreotide Sales by Manufacturers
  6. 4.2.1 Global Octreotide Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Octreotide Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Octreotide Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Octreotide Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Octreotide Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Octreotide Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Octreotide Manufacturers, Product Type & Application
  13. 4.7 Global Octreotide Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Octreotide Market CR5 and HHI
  16. 4.8.2 2025 Octreotide Tier 1, Tier 2, and Tier 3
5 Octreotide Market by Type
  1. 5.1 Global Octreotide Revenue by Type
  2. 5.1.1 Global Octreotide Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Octreotide Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Octreotide Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Octreotide Sales by Type
  6. 5.2.1 Global Octreotide Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Octreotide Sales by Type (2021-2032) & (Gram)
  8. 5.2.3 Global Octreotide Sales Market Share by Type (2021-2032)
  9. 5.3 Global Octreotide Price by Type
6 Octreotide Market by Application
  1. 6.1 Global Octreotide Revenue by Application
  2. 6.1.1 Global Octreotide Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Octreotide Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Octreotide Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Octreotide Sales by Application
  6. 6.2.1 Global Octreotide Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Octreotide Sales by Application (2021-2032) & (Gram)
  8. 6.2.3 Global Octreotide Sales Market Share by Application (2021-2032)
  9. 6.3 Global Octreotide Price by Application
7 Company Profiles
  1. 7.1 Novartis
  2. 7.1.1 Novartis Company Information
  3. 7.1.2 Novartis Business Overview
  4. 7.1.3 Novartis Octreotide Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Novartis Octreotide Product Portfolio
  6. 7.1.5 Novartis Recent Developments
  7. 7.2 Sun Pharmaceutical
  8. 7.2.1 Sun Pharmaceutical Company Information
  9. 7.2.2 Sun Pharmaceutical Business Overview
  10. 7.2.3 Sun Pharmaceutical Octreotide Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Sun Pharmaceutical Octreotide Product Portfolio
  12. 7.2.5 Sun Pharmaceutical Recent Developments
  13. 7.3 Chengdu Tiantaishan pharmaceutical
  14. 7.3.1 Chengdu Tiantaishan pharmaceutical Company Information
  15. 7.3.2 Chengdu Tiantaishan pharmaceutical Business Overview
  16. 7.3.3 Chengdu Tiantaishan pharmaceutical Octreotide Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Chengdu Tiantaishan pharmaceutical Octreotide Product Portfolio
  18. 7.3.5 Chengdu Tiantaishan pharmaceutical Recent Developments
  19. 7.4 Sinopharm A-Think Pharmaceuticals
  20. 7.4.1 Sinopharm A-Think Pharmaceuticals Company Information
  21. 7.4.2 Sinopharm A-Think Pharmaceuticals Business Overview
  22. 7.4.3 Sinopharm A-Think Pharmaceuticals Octreotide Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Sinopharm A-Think Pharmaceuticals Octreotide Product Portfolio
  24. 7.4.5 Sinopharm A-Think Pharmaceuticals Recent Developments
  25. 7.5 Sihuan Pharmaceutical Holdings Group
  26. 7.5.1 Sihuan Pharmaceutical Holdings Group Company Information
  27. 7.5.2 Sihuan Pharmaceutical Holdings Group Business Overview
  28. 7.5.3 Sihuan Pharmaceutical Holdings Group Octreotide Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Sihuan Pharmaceutical Holdings Group Octreotide Product Portfolio
  30. 7.5.5 Sihuan Pharmaceutical Holdings Group Recent Developments
  31. 7.6 Shanghai Soho-Yiming Pharmaceuticals
  32. 7.6.1 Shanghai Soho-Yiming Pharmaceuticals Company Information
  33. 7.6.2 Shanghai Soho-Yiming Pharmaceuticals Business Overview
  34. 7.6.3 Shanghai Soho-Yiming Pharmaceuticals Octreotide Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Shanghai Soho-Yiming Pharmaceuticals Octreotide Product Portfolio
  36. 7.6.5 Shanghai Soho-Yiming Pharmaceuticals Recent Developments
  37. 7.7 Yibin Pharmaceutical
  38. 7.7.1 Yibin Pharmaceutical Company Information
  39. 7.7.2 Yibin Pharmaceutical Business Overview
  40. 7.7.3 Yibin Pharmaceutical Octreotide Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Yibin Pharmaceutical Octreotide Product Portfolio
  42. 7.7.5 Yibin Pharmaceutical Recent Developments
8 North America
  1. 8.1 North America Octreotide Market Size by Type
  2. 8.1.1 North America Octreotide Revenue by Type (2021-2032)
  3. 8.1.2 North America Octreotide Sales by Type (2021-2032)
  4. 8.1.3 North America Octreotide Price by Type (2021-2032)
  5. 8.2 North America Octreotide Market Size by Application
  6. 8.2.1 North America Octreotide Revenue by Application (2021-2032)
  7. 8.2.2 North America Octreotide Sales by Application (2021-2032)
  8. 8.2.3 North America Octreotide Price by Application (2021-2032)
  9. 8.3 North America Octreotide Market Size by Country
  10. 8.3.1 North America Octreotide Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Octreotide Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Octreotide Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Octreotide Market Size by Type
  2. 9.1.1 Europe Octreotide Revenue by Type (2021-2032)
  3. 9.1.2 Europe Octreotide Sales by Type (2021-2032)
  4. 9.1.3 Europe Octreotide Price by Type (2021-2032)
  5. 9.2 Europe Octreotide Market Size by Application
  6. 9.2.1 Europe Octreotide Revenue by Application (2021-2032)
  7. 9.2.2 Europe Octreotide Sales by Application (2021-2032)
  8. 9.2.3 Europe Octreotide Price by Application (2021-2032)
  9. 9.3 Europe Octreotide Market Size by Country
  10. 9.3.1 Europe Octreotide Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Octreotide Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Octreotide Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Octreotide Market Size by Type
  2. 10.1.1 China Octreotide Revenue by Type (2021-2032)
  3. 10.1.2 China Octreotide Sales by Type (2021-2032)
  4. 10.1.3 China Octreotide Price by Type (2021-2032)
  5. 10.2 China Octreotide Market Size by Application
  6. 10.2.1 China Octreotide Revenue by Application (2021-2032)
  7. 10.2.2 China Octreotide Sales by Application (2021-2032)
  8. 10.2.3 China Octreotide Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Octreotide Market Size by Type
  2. 11.1.1 Asia Octreotide Revenue by Type (2021-2032)
  3. 11.1.2 Asia Octreotide Sales by Type (2021-2032)
  4. 11.1.3 Asia Octreotide Price by Type (2021-2032)
  5. 11.2 Asia Octreotide Market Size by Application
  6. 11.2.1 Asia Octreotide Revenue by Application (2021-2032)
  7. 11.2.2 Asia Octreotide Sales by Application (2021-2032)
  8. 11.2.3 Asia Octreotide Price by Application (2021-2032)
  9. 11.3 Asia Octreotide Market Size by Country
  10. 11.3.1 Asia Octreotide Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Octreotide Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Octreotide Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Octreotide Market Size by Type
  2. 12.1.1 SAMEA Octreotide Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Octreotide Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Octreotide Price by Type (2021-2032)
  5. 12.2 SAMEA Octreotide Market Size by Application
  6. 12.2.1 SAMEA Octreotide Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Octreotide Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Octreotide Price by Application (2021-2032)
  9. 12.3 SAMEA Octreotide Market Size by Country
  10. 12.3.1 SAMEA Octreotide Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Octreotide Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Octreotide Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Octreotide Value Chain Analysis
  2. 13.1.1 Octreotide Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Octreotide Production Mode & Process
  6. 13.2 Octreotide Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Octreotide Distributors
  9. 13.2.3 Octreotide Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst